Uniting the power of multiple medicines in a single molecule
Diseases are multi-faceted. We know medicines must be too. Our modular platforms unite the power of multiple biologics into single molecules to combat complex diseases.
Leading with experience
Over decades, our leaders have served at the highest levels of academia, government and industry. They have supported scientific excellence, translational research and nurtured collaborative environments that have delivered medical breakthroughs to patients.
OPKO Health, President and Vice Chairman of the Board of Directors
Dr. Elias Zerhouni co-founded ModeX Therapeutics and is Chairman of the Board. Dr. Zerhouni started his academic career in biomedical imaging and engineering; he served as Chair of his department, and then Executive Vice-Dean...
OPKO Health, Chief Innovation Officer and Board Director
Dr. Gary Nabel co-founded ModeX Therapeutics and is President and CEO. Dr. Nabel started his academic career at the Howard Hughes Medical Institute at the University of Michigan. He then joined the National Institutes...
Dr. John Mascola joined ModeX Therapeutics as Chief Scientific Officer in 2022. He is an accomplished physician-scientist, virologist and immunologist, and was most recently the Director of the Vaccine Research Center, NIAID, NIH where...
Dr. Elizabeth (Betsy) Nabel is Advisory Board Chair at OPKO Health, providing strategic counsel to ModeX Therapeutics, and is Professor of Medicine Emerita at Harvard Medical School. From 2010 to 2021, she served as...
Dr. Vijay Chhajlani is Chief Technology Officer at ModeX and has more than 25 years of experience in the pharmaceutical industry, with extensive knowledge of discovery and development of small molecule as well as...
Dr. Ji Zhang is Chief Operating Officer of ModeX Therapeutics. He was most recently Senior Partner and Senior Vice President of Enterprise R&D Operations for Flagship Pioneering, and previously Senior Vice President, Global Head...
The efforts at ModeX build on the experience of our leadership team to advance technologies with the potential to shift the paradigm in drug development.